Anchor Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.33K | Hold |
40
| – | – | ﹤0.01% | 853 |
|
|
2025
Q4 | $7.04K | Hold |
40
| – | – | ﹤0.01% | 859 |
|
|
2025
Q3 | $5.6K | Hold |
40
| – | – | ﹤0.01% | 890 |
|
|
2025
Q2 | $5.02K | Hold |
40
| – | – | ﹤0.01% | 891 |
|
|
2025
Q1 | $5.47K | Hold |
40
| – | – | ﹤0.01% | 871 |
|
|
2024
Q4 | $6.12K | Hold |
40
| – | – | ﹤0.01% | 860 |
|
|
2024
Q3 | $7.75K | Hold |
40
| – | – | ﹤0.01% | 824 |
|
|
2024
Q2 | $9.27K | Sell |
40
-5
| -11% | -$1.09K | ﹤0.01% | 763 |
|
|
2024
Q1 | $9.7K | Buy |
45
+5
| +13% | +$1.17K | ﹤0.01% | 782 |
|
|
2023
Q4 | $10.4K | Hold |
40
| – | – | ﹤0.01% | 744 |
|
|
2023
Q3 | $10.3K | Hold |
40
| – | – | ﹤0.01% | 739 |
|
|
2023
Q2 | $11.4K | Hold |
40
| – | – | ﹤0.01% | 716 |
|
|
2023
Q1 | $11.1K | Hold |
40
| – | – | ﹤0.01% | 725 |
|
|
2022
Q4 | $11.1K | Sell |
40
-40
| -50% | -$11.3K | ﹤0.01% | 704 |
|
|
2022
Q3 | $21.4K | Hold |
80
| – | – | ﹤0.01% | 620 |
|
|
2022
Q2 | $16.3K | Hold |
80
| – | – | ﹤0.01% | 678 |
|
|
2022
Q1 | $16.8K | Hold |
80
| – | – | ﹤0.01% | 689 |
|
|
2021
Q4 | $19.2K | Sell |
80
-30
| -27% | -$7.71K | ﹤0.01% | 704 |
|
|
2021
Q3 | $31.1K | Hold |
110
| – | – | ﹤0.01% | 577 |
|
|
2021
Q2 | $38.1K | Hold |
110
| – | – | 0.01% | 568 |
|
|
2021
Q1 | $30.8K | Hold |
110
| – | – | ﹤0.01% | 573 |
|
|
2020
Q4 | $26.9K | Hold |
110
| – | – | ﹤0.01% | 559 |
|
|
2020
Q3 | $31.2K | Hold |
110
| – | – | 0.01% | 510 |
|
|
2020
Q2 | $29.4K | Hold |
110
| – | – | 0.01% | 505 |
|
|
2020
Q1 | $34.8K | Hold |
110
| – | – | 0.01% | 479 |
|
|
2019
Q4 | $32.6K | Hold |
110
| – | – | 0.01% | 516 |
|
|
2019
Q3 | $25.6K | Buy |
110
+40
| +57% | +$9.31K | 0.01% | 535 |
|
|
2019
Q2 | $16.4K | Hold |
70
| – | – | ﹤0.01% | 579 |
|
|
2019
Q1 | $16.5K | Buy |
70
+30
| +75% | +$9.45K | ﹤0.01% | 578 |
|
|
2018
Q4 | $12K | Buy |
+40
| New | +$12.8K | ﹤0.01% | 602 |
|
|
2016
Q4 | – | Sell |
-40
| Closed | -$12.5K | – | 675 |
|
|
2016
Q3 | $12.5K | Hold |
40
| – | – | ﹤0.01% | 505 |
|
|
2016
Q2 | $9.67K | Hold |
40
| – | – | ﹤0.01% | 519 |
|
|
2016
Q1 | $10.4K | Buy |
+40
| New | +$10.6K | ﹤0.01% | 486 |
|
Other funds holding BIIB
VCM
VPM
Anchor Investment Management's BIIB Position: Q1 2026 in Review
Anchor Investment Management held its Biogen (BIIB) position steady in Q1 2026 at 40 shares worth $7.33K. The position accounts for ﹤0.01% of the portfolio, ranked #853.
Anchor Investment Management first reported a position in BIIB in Q1 2016 and has held it in 33 quarters since. The position peaked at $38.1K in Q2 2021. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Anchor Investment Management held 40 shares of Biogen worth $7.33K as of Q1 2026.
- Anchor Investment Management left its Biogen share count unchanged in Q1 2026.
- Biogen made up ﹤0.01% of Anchor Investment Management's portfolio in Q1 2026, its #853 holding.
- Anchor Investment Management first reported a position in Biogen in Q1 2016 and has held it in 33 quarters since.
- Anchor Investment Management's Biogen position peaked at $38.1K in Q2 2021.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.